DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries. Manufactured by US ...

John Stewart, Director of Specialised Commissioning at NHS England said: “For babies born very prematurely, the risk of ...

Misperceptions around a vaccine’s plaque-forming unit (PFU) level are leading to inaccurate conclusions about vaccine protection ...

The rates of BSIs and other invasive bacterial infections were high among hospitalized veterans with evidence of substance use.

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

We report the first documented case of a cutaneous nontuberculous mycobacterial infection, specifically Mycobacterium abscessus , in a patient with psoriatic dactylitis undergoing treatment with a ...

A nurse in the dispensary of a clinic in Mhlosheni, Eswatini, which once had the world’s highest rate of H.I.V. infection. From January to April, nearly 5,000 people with H.I.V. failed to pick ...